The review discusses fifty eight peptides in various clinical phases, indicating a robust pipeline of peptide therapies focusing on PPIs. Co-formulation with other permeation enhancers, enzyme inhibitors, and hydrogels have also been used to allow the oral administration of other peptide medication, like octreotide and insulin, that are now in https://jamesk108dkn5.cosmicwiki.com/user